glp 1 mechanism Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Mechanisms of Action and Therapeutic

No, GLP-1 receptor agonists should not replace statins as first-line therapy for hypercholesterolaemia

PMCID: PMC12075970

Although not FDA-approved for non-diabetic use, many studies have shown semaglutide's effectiveness in non-diabetics seeking weight loss

These medications can be incredibly helpful, but theyre not risk-free, especially during pregnancy. The study found that 2.2% of women became pregnant within six months of starting GLP-1 treatment with pregnancy rates highest among younger women with diabetes, and among women without diabetes in their early thirties

66% of the platforms we reviewed offered compounded GLP-1s

However, the authors note that the certainty of evidence was low